Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic Type 1 diabetes.

A Piñero-Piloña1, P Raskin

  • 1Department of Internal Medicine, University of Texas Southwestern Medical School, G4.100, 5323 Harry Hines Boulevard, Dallas, TX 75390-8858, USA. antonio.pinero@utsouthwestern.edu

Journal of Diabetes and Its Complications
|November 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).

Diabetes, obesity & metabolism·2016
Same author

AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2015
Same author

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.

Diabetes, obesity & metabolism·2011
Same author

Glycaemic control with liraglutide: the phase 3 trial programme.

International journal of clinical practice. Supplement·2010
Same author

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.

Diabetes, obesity & metabolism·2009
Same journal

Diabetes and the risk of entrapment neuropathies of the upper and lower extremity - A propensity score-matched cohort study.

Journal of diabetes and its complications·2026
Same journal

Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes.

Journal of diabetes and its complications·2026
Same journal

From obesity guideline to diabetes practice: WHO GLP-1 recommendations between promise, uncertainty and global inequity.

Journal of diabetes and its complications·2026
Same journal

Impact of the AWGS2025 criteria on sarcopenia prevalence and microvascular complications in individuals with type 2 diabetes in Japan: a cross-sectional study.

Journal of diabetes and its complications·2026
Same journal

Clinical inertia in patients with type 2 diabetes: A retrospective cohort study using an electronic healthcare database in Japan.

Journal of diabetes and its complications·2026
Same journal

From static lipids to dynamic risk: The role of atherogenic index of plasma in prediabetes.

Journal of diabetes and its complications·2026
See all related articles

Idiopathic Type 1 diabetes, common in obese African Americans, presents like Type 1 but behaves like Type 2. Insulin therapy appears more effective for long-term glycemic control than oral agents.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Immunology

Background:

  • Idiopathic Type 1 diabetes is a prevalent form of diabetes.
  • It disproportionately affects obese African American individuals in urban settings.
  • Clinical presentation mimics Type 1 diabetes (e.g., diabetic ketoacidosis) but often follows a Type 2 diabetes-like course.

Purpose of the Study:

  • To review existing pathophysiological and clinical studies on idiopathic Type 1 diabetes.
  • To elucidate the characteristics and management of this specific diabetic subtype.

Main Methods:

  • Review of available pathophysiological studies.
  • Analysis of clinical data from affected patients.
  • Synthesis of findings from previous research.

Related Experiment Videos

Main Results:

  • The natural history and pathogenesis remain largely unknown due to limited long-term studies.
  • Treatment with diet and oral agents shows variable patient responses.
  • Insulin therapy suggests superior long-term glycemic control compared to oral agents.

Conclusions:

  • Idiopathic Type 1 diabetes presents a unique clinical challenge with an unclear etiology.
  • Potential pathogenic links include lipotoxicity, glucose toxicity, or transcription factor dysfunction.
  • Further research is needed to understand its pathogenesis and optimize treatment strategies.